Bioinformatics analyses have revealed that the overexpression of BUB1B is associated with an unfavorable prognosis in liver cancer, pancreatic cancer, and lung cancer based on the TCGA database (Dong et al., 2019; Yang et al., 2019; Dai et al., 2020). This evidence concerns the gene BUB1B and pancreatic neoplasm.